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assigned to microbes) in the patients with severe pneumonia
with novel inﬂuenza A H7N9 virus infection within 6 days to
27 days of illness onset
6 9 12 15 18 21 24 27Bloodstream infections and cytokine dysregulation are associated
with high rates of morbidity and mortality among patients with
inﬂuenza virus H7N9 infection. Here, massively parallel RNA
sequencing was used to serially analyse plasma viruses and
cytokine transcriptomes of a fatal H7N9-related case at
successive times throughout the clinical course of infection. The
results showed that acute viraemia with H7N9 virus occurred,
and the virus was sensitive to antiviral therapy with oseltamivir.
In addition, a lot of genome sequences from Acinetobacter
baumannii were detected in blood on day 18 after illness onset
when the bacteria were cultured. In parallel, longitudinal mRNA
expression patterns of host cytokines associated with infection
were analysed. This study illustrated the potential of RNA-
sequencing to explore the plasma virome and expression proﬁle
of the infected host cytokines simultaneously in infectious disease.
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in China in March 2013, there have been two major epidemic
waves of human infections to date and sporadic cases have
continued to be reported [1]. Previous studies showed that
most patients were hospitalized with severe disease, particu-
larly pneumonia and acute respiratory distress syndrome,
leading to high rates of intensive care unit admissions and
mechanical ventilation, and >30% mortality [2].
Bloodstream infections and cytokine dysregulation are associ-
ated with high rates of morbidity and mortality among patients
with inﬂuenza virus H7N9 infection despite advances in antimi-
crobial therapy and supportive care [3]. However, our under-
standing of the relative contributions of viral and host factors to
severe inﬂuenza, including theseH7N9cases, is far fromcomplete.
Massively parallel RNA sequencing (RNA-seq) based on
randomly primed cDNA synthesis has the potential to obtain a
comprehensive, largely unbiased qualitative and quantitative
view of all RNA in a sample. It therefore enables detection of
genomes from highly divergent lineages, unrelated co-infectants,
or even novel viruses in clinical samples from infectious disease.
Meanwhile, total RNA-seq can also provide an expression
proﬁle of the infected host simultaneously with viral sequence
generation [4]. In this study, total RNA-seq was used to serially
analyse plasma viruses and cytokine transcriptomes of a fatal
H7N9-related case at successive times following infection
during the clinical course.
A 61-year-old female patient with severe pneumonia and
acute respiratory distress syndrome was admitted on 18 Julynﬂuenza A H7N9 virus 105 6 17 1 6 22 13 1
uid herpesvirus 1 20 79 19 32 13 7 5 2
ndogenous retrovirus 6 8 10 11 6 11 10 13
lphapapillomavirus 1 1 2 1 3 2 1 0
cinetobacter baumannii 3 0 7 12 279 54 69 76
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FIG. 1. Representative cytokine responses at the gene transcriptional level at various times during avian inﬂuenza A H7N9 virus infection. (a) Cytokine
expression peaked at the time of peak viraemia and decreased with the decline in viral load, including T helper type 17 (Th17) cytokines transforming
growth factor-β (TGF-β), interleukin-29 (IL-29), Th1 and Th2 cytokines, IL-4 and macrophage inﬂammatory protein-1β (MIP-1β). (b) No obvious
changes occurred as the viral load decreased, but the level peaked during the clinical course when secondary bacterial infection developed, including
cytokines macrophage inﬂammatory protein-β (MIP-1β), eotaxin, MIP-3α and IL-17. (c) Over-expressed cytokine genes before the patient’s death,
including IL-2, tumour necrosis factor-α (TNF-α), interferon-α (IFN-α) and anti-inﬂammatory cytokines IL-1ra and CCL17 and CCL24.
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subtyped as the novel inﬂuenza A (H7N9) virus by real-time
PCR as described previously [5] and antiviral treatment was
initiated on day 6. A chest radiograph revealed interstitial
pneumonia in the left upper lung and follow-up chest radio-
graphs showed ground glass opacity and lower lung consoli-
dation. On days 6–12, procalcitonin was in the 5–6 ng/mL
range and the white blood cell (leucocyte) count ﬂuctuated in
the 7.2 × 109 to 13.11 × 109/L range. Carbapenem-resistant
multidrug-resistant Acinetobacter baumannii was cultured from
blood till day 18 after disease onset. Acute respiratory distress
syndrome and septic shock developed in the patient on day 28
and she died on day 29.
To stratify the distinct time points during the illness, serial
sampling of blood, corresponding to days 6, 9, 12, 15, 18, 21, 24
and 27 after illness onset, were performed, and the ﬁrst blood
sample of day 6 was collected before antiviral treatment. Total
RNA was isolated from blood samples collected in PAXgene
Blood RNA Tubes (Qiagen, Hilden, Germany), and reverse-
transcribed to double-stranded DNA and subjected to
sequencing on Illumina Solexa GAII with read length of 80 bp.
Adapters, duplicate and low-quality reads were removed, and
the remaining reads were mapped to the human reference
genome. The gene expression proﬁles for host cytokines in
blood samples were analysed using Tophat (version 2.0.10) and
Cufﬂinks (version 2.1.1) software using the default parameters.
Unmapped non-human reads were aligned to the NCBI non-
redundant nucleotide database by BLAST software (version
2.2.22) for the identiﬁcation of viruses.
An acute viraemia with H7N9 virus (105 reads) was
observed, whereas the viral nucleic acid of H7N9 was not
detected after 3 days of antiviral therapy except for several
endogenous viruses, which was consistent with the results of
serial real-time PCR. Further, a lot of sequences from
A. baumannii were detected in blood when bacteria were
cultured on day 18 after illness onset, probably indicating a
secondary bacterial infection in the blood (Table 1).
Total RNA-seq of serial bloods allowed simultaneous analysis
of blood microbes and host cytokines at the gene transcription
level following H7N9 virus infection. Changing patterns of
representative cytokines could be illustrated in three categories
(Fig. 1): (a) mRNA expression of cytokines peaked at the time
of peak viraemia and decreased with the decline in viral load,
including the anti-inﬂammatory cytokines (transforming growth
factor-β, interleukin-4 (IL-4)), chemoattractant cytokines
(macrophage inﬂammatory protein-2β (MIP-2β), regulated on
activation normal T cell expressed and secreted), and IL-29
(Fig. 1a); (b) the level peaked during the clinical course when
secondary A. baumannii infection developed, which described
chemoattractant cytokines MIP-1β, eotaxin, MIP-3α, pleiotropicClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Incytokines IL-17 and growth factor platelet-derived growth
factor -bb (Fig. 1b); (c) mRNA expression of cytokine peaked
during the recovery phase from 15 days after disease onset,
which included pro-inﬂammatory cytokines IL-2, tumour ne-
crosis factor-α, interferon-α and anti-inﬂammatory cytokines
IL-1ra and CCL17 and CCL24 (Fig. 1c).
In this study, we demonstrated an initial attempt to use total
RNA-seq to explore the blood microbiomes and the mRNA
expression of cytokines of a patient with a fatal novel inﬂuenza
A (H7N9) virus infection, simultaneously. RNA-seq of blood
revealed that viraemia with inﬂuenza A H7N9 virus occurred as
high pathogenicity avian inﬂuenza A H5N1 virus reported
before. The inﬂuenza A H7N9 virus was susceptible to osel-
tamivir therapy, which is revealed by a high load of 105 reads in
blood before oseltamivir treatment and only a few reads were
detected after a 3-day antiviral treatment. Previous studies
showed that high concentrations of inﬂammatory cytokines,
like IL-6, IL-8 and MIP-1β, in plasma were predictive of a less
favourable or fatal outcome in patients with the novel inﬂuenza
A H7N9 virus [2,6]. Our observations, at the mRNA level,
indicate that sustained high levels of host inﬂammatory factors,
consisting of a set of distinct cytokine storms associated with
disease stage, may contribute to disease progression and death.
This study illustrated the potential of RNA-seq to explore the
virus and host inﬂammatory factors in infectious respiratory
disease. With the advances in deep sequence technology, we
expect that unbiased next-generation sequencing will be appli-
cable in the diagnosis of infections.FundingNational S&T Major Project, ‘China Mega-Project for Infectious
Disease’ (grant no. 2013ZX10004-001), The Nonproﬁt In-
dustry Research Project of the Chinese National Health and
Family Planning Commission (grant No. 201402001), the Na-
tional Natural Science Foundation of China (grant no.
81070005/H0104, 81030032/H19 and 81271840) and PUMC
Youth Fund (grant no. 33320140031).Transparency declarationThe authors have no potential conﬂicts of interest to declare.AcknowledgementsWe acknowledge Drs Xiao Tang, Hang Yong He, Jun Wan and
Chengjun Ban for taking care of the patient and collectingfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 713.e1–713.e4
713.e4 Clinical Microbiology and Infection, Volume 21 Number 7, July 2015 CMIclinical data. We are grateful to BinBin Li, Fang Li, Shanshan
Wang, Chunlei Wang, Chunxia Yang, Peng Wang and Hong
Shen for culture, identiﬁcation and in vitro susceptibility testing
of clinical samples.
References[1] Feng L, Wu J, Liu X, Yang P, Tsang T, Jiang H, et al. Clinical severity of
human infections with avian inﬂuenza A(H7N9) virus, China 2013/14.
Euro Surveill 2014;19(49).
[2] Wang Z, Zhang A, Wan Y, Liu X, Qiu C, Xi X, et al. Early hyper-
cytokinemia is associated with interferon-induced transmembrane
protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl
Acad Sci U S A 2014;111:769–74.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect[3] Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, et al.
Impact of rapid organism identiﬁcation via matrix-assisted laser
desorption/ionization time-of-ﬂight combined with antimicrobial stew-
ardship team intervention in adult patients with bacteremia and candi-
demia. Clin Infect Dis 2013;57:1237–45.
[4] Matranga CB, Andersen KG, Winnicki S, Busby M, Gladden AD,
Tewhey R, et al. Enhanced methods for unbiased deep sequencing of
Lassa and Ebola RNA viruses from clinical and biological samples.
Genome Biol 2014;15:519.
[5] Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection
with a novel avian-origin inﬂuenza A (H7N9) virus. N Engl J Med
2013;368(20):1888–97.
[6] Chi Y, Zhu Y, Wen T, Cui L, Ge Y, Jiao Y, et al. Cytokine and che-
mokine levels in patients infected with the novel avian inﬂuenza A
(H7N9) virus in China. J Infect Dis 2013;208:1962–7.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 713.e1–713.e4
